Mexico - Delayed Quote MXN
Incyte Corporation (INCY.MX)
1,430.49
0.00
(0.00%)
At close: March 6 at 12:37:40 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 22 | 21 |
| Avg. Estimate | 1.15B | 1.21B | 4.7B | 5.18B |
| Low Estimate | 1.13B | 1.18B | 4.58B | 4.83B |
| High Estimate | 1.19B | 1.27B | 4.82B | 5.51B |
| Year Ago Sales | 1.04B | 1.14B | 4.24B | 4.7B |
| Sales Growth (year/est) | 10.14% | 6.59% | 10.94% | 10.06% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INCY.MX | -- | -- | -- | -- |
| S&P 500 | 12.37% | 3.19% | 8.03% | 13.82% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/30/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/30/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 4/21/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/24/2025 |
| Maintains | Truist Securities: Hold to Hold | 3/18/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 3/18/2025 |